Yf. Mahe et al., A MINOXIDIL-RELATED COMPOUND LACKING A C6 SUBSTITUTION STILL EXHIBITSSTRONG ANTI-LYSYL HYDROXYLASE-ACTIVITY IN-VITRO, Skin pharmacology, 9(3), 1996, pp. 177-183
It has been previously reported that minoxidil inhibits the activity o
f lysyl hydroxylase (LH), an enzyme which catalyzes the formation of h
ydroxylysine, which is necessary for proper maturation of collagen at
the transcriptional and enzymatic levels. Using the reverse transcript
ase-polymerase chain reaction, we confirmed that this inhibition occur
red at least at the transcriptional level. Furthermore, we took advant
age of this sensitive and rapid method to perform a quantitative struc
ture activity relation study using several compounds structurally rela
ted to minoxidil. We found that when the C6 of the pyrimidinyl moiety
was substituted, it had to be by a tertiary nitrogen, i.e. an N-piperi
din ring for the inhibition of LH mRNA synthesis to be observed. Surpr
isingly, however, we found that 2,4-diamino-pyrimidin-3-oxide, a new c
ompound lacking an organic moiety para to the nitroxide oxygen, also r
etained a high inhibitory effect on LH mRNA expression, comparable to
that of minoxidil. We thus conclude that the presence of a substituent
para to the nitroxide oxygen is dispensable for inhibition of LH mRNA
to be observed in vitro. This brings new insights into the design of
therapeutic agents useful in any condition where an overproduction of
mature collagen is unwanted, i.e. accelerated wound healing, keloids a
nd localized scleroderma.